-
2
-
-
0023686219
-
Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview
-
(1988)
Mutat. Res.
, vol.202
, pp. 285-306
-
-
DeFlora, S.1
Ramel, C.2
-
6
-
-
0020431144
-
Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. G.H.A. Clowes Memorial Lecture
-
(1982)
Cancer Res.
, vol.42
, pp. 4875-4917
-
-
Conney, A.H.1
-
8
-
-
0028152397
-
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis
-
(1994)
Proc. Natl. Acad. Sci. U.S.A.
, vol.91
, pp. 11733-11737
-
-
Lee, W.H.1
Morton, R.A.2
Epstein, J.I.3
Brooks, J.D.4
Campbell, P.A.5
Bova, G.S.6
Hsich, W.S.7
Isaacs, W.B.8
Nelson, W.G.9
-
9
-
-
0035138171
-
Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyrimidine (N-OH-PhIP) cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1
-
(2001)
Cancer Res.
, vol.61
, pp. 103-109
-
-
Nelson, C.P.1
Kidd, L.R.2
Saubageot, J.3
Issacs, W.B.4
DeMarzo, A.5
Groopman, J.D.6
Nelson, W.G.7
Kensler, T.W.8
-
11
-
-
0029680939
-
Transfection of glutathione S-transferase (GST)-pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide
-
(1996)
Cancer Res.
, vol.56
, pp. 3577-3582
-
-
Ban, N.1
Takahaski, Y.2
Takayama, T.3
Kura, T.4
Katahira, T.5
Sakamaki, S.6
Niitsu, Y.7
-
14
-
-
0033805156
-
Mammalian class theta GST and differential susceptibility to carcinogens
-
(2000)
Mutat. Res.
, vol.463
, pp. 247-283
-
-
Landi, S.1
-
15
-
-
0020048767
-
Isolation and identification of kahweol palmitate and cafestrol palmitate as active constituents of green coffee beans that enhance glutathione S-transferase activity in the mouse
-
(1982)
Cancer Res.
, vol.42
, pp. 1193-1198
-
-
Lam, L.K.T.1
Sparnins, V.L.2
Wattenberg, L.W.3
-
26
-
-
0022763396
-
Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) on carcinogenesis induced by benzo[a]pyrene, diethylnitrosamine and uracil mustard
-
(1986)
Carcinogenesis
, vol.7
, pp. 1379-1381
-
-
Wattenberg, L.W.1
Bueding, E.2
-
27
-
-
0028630961
-
Strategy and planning for chemopreventive drug development: Clinical development plans
-
(1994)
J. Cell. Biochem.
, vol.20 S
, pp. 55-299
-
-
Kelloff, G.J.1
Crowell, J.A.2
Boone, C.W.3
Steele, V.E.4
Lubet, R.A.5
Greenwald, P.6
Alberts, C.S.7
Covey, J.M.8
Doody, L.A.9
Knapp, G.G.10
Nayfield, S.11
Parkinson, D.R.12
Prasad, V.K.13
Prorok, P.C.14
Sausville, E.A.15
Sigman, C.C.16
-
31
-
-
0023204238
-
Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones
-
(1987)
Cancer Res.
, vol.47
, pp. 4271-4277
-
-
Kensler, T.W.1
Egner, P.A.2
Dolan, P.M.3
Groopman, J.D.4
Roebuck, B.D.5
-
36
-
-
0028865229
-
1 metabolism in human hepatocytes in primary culture
-
(1995)
Cancer Res.
, vol.55
, pp. 5574-5579
-
-
Langouët, S.1
Coles, B.2
Morel, F.3
Becquemont, L.4
Beaune, P.5
Guengerich, F.P.6
Ketterer, B.7
Guillouzo, A.8
-
37
-
-
0034014663
-
Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives, and sulforaphane
-
(2000)
Chem. Res. Toxicol.
, vol.13
, pp. 245-252
-
-
Langouët, S.1
Furge, L.L.2
Kerriguy, N.3
Nakamura, K.4
Guillouzo, A.5
Guengerich, F.P.6
-
48
-
-
0031577292
-
An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements
-
(1997)
Biochem. Biophys. Res. Commun.
, vol.236
, pp. 313-322
-
-
Itoh, K.1
Chiba, T.2
Takahashi, S.3
Ishii, T.4
Igarashi, K.5
Katoh, Y.6
Oyake, T.7
Hayashi, N.8
Satoh, K.9
Hatayama, I.10
Yamamoto, M.11
Nabeshima, Y.12
-
55
-
-
0028893618
-
Approaches to the development and marketing approval of drugs that prevent cancer
-
(1995)
Cancer Epidemiol. Biomarkers Prev.
, vol.4
, pp. 1-10
-
-
Kelloff, G.J.1
Johnson, J.R.2
Crowell, J.A.3
Boone, C.W.4
DeGeorge, J.J.5
Steele, V.E.6
Mehta, M.U.7
Temeck, J.W.8
Schmidt, W.J.9
Burke, G.10
Greenwald, P.11
Temple, R.J.12
-
56
-
-
0028832190
-
Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent
-
(1995)
Clin. Cancer Res.
, vol.1
, pp. 1133-1138
-
-
Gupta, E.1
Olopade, O.I.2
Ratain, M.J.3
Mick, R.4
Baker, T.M.5
Berezin, F.K.6
Benson III, A.B.7
Dolan, M.E.8
-
58
-
-
9544250360
-
Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz
-
(1996)
J. Clin. Invest.
, vol.98
, pp. 1210-1217
-
-
O'Dwyer, P.J.1
Szarka, C.E.2
Yao, K.-S.3
Halbherr, T.C.4
Pfeiffer, G.R.5
Green, F.6
Gallo, J.M.7
Brennan, J.8
Frucht, H.9
Goosenberg, E.B.10
Hamilton, T.C.11
Litwin, S.12
Balshem, A.M.13
Engstrom, P.F.14
Clapper, M.L.15
-
59
-
-
33646234399
-
Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China
-
(1996)
Cancer Epidemiol. Biomarkers Prev.
, vol.5
, pp. 253-261
-
-
Wang, J.-S.1
Qian, G.-S.2
Zarba, A.3
He, X.4
Zhu, Y.-R.5
Zhang, B.-C.6
Jacobson, L.7
Gange, S.J.8
Muñoz, A.9
Kensler, T.W.10
Groopman, J.D.11
-
60
-
-
16944362010
-
Oltipraz chemoprevention trial in Qidong, People's Republic of China: Study design and clinical outcomes
-
(1997)
Cancer Epidemiol. Biomarkers Prev.
, vol.6
, pp. 257-265
-
-
Jacobson, L.P.1
Zhang, B.-C.2
Zhu, Y.-R.3
Wang, J.-B.4
Wu, Y.5
Zhang, Q.-N.6
Yu, L.-Y.7
Qian, G.-S.8
Kuang, S.-Y.9
Li, Y.-F.10
Fang, X.11
Zarba, A.12
Chen, B.13
Enger, C.14
Davidson, N.E.15
Gorman, M.B.16
Gordon, G.B.17
Prochaska, H.J.18
Egner, P.A.19
Groopman, J.D.20
Muñoz, A.21
Helzlsouer, K.J.22
Kensler, T.R.23
more..
-
61
-
-
0343545529
-
Oltipraz chemoprevention trial in Qidong, People's Republic of China: Modulation of serum aflatoxin albumin adduct biomarkers
-
(1998)
Cancer Epidemiol. Biomarkers Prev.
, vol.7
, pp. 127-134
-
-
Kensler, T.W.1
He, X.2
Otieno, M.3
Egner, P.A.4
Jacobson, L.P.5
Chen, B.6
Wang, J.-S.7
Zhu, Y.-R.8
Zhang, B.-C.9
Wang, J.-B.10
Wu, Y.11
Zhang, Q.-N.12
Qian, G.-S.13
Kuang, S.-Y.14
Fang, S.15
Li, Y.-F.16
Yu, L.-Y.17
Prochaska, H.J.18
Davidson, N.E.19
Gordon, G.B.20
Gorman, M.B.21
Zarba, A.22
Enger, C.23
Muñoz, A.24
Helzlsouer, K.J.25
Groopman, J.26
Egner, P.A.27
Jacobson, L.P.28
Chen, B.29
Wang, J.-S.30
Zhu, Y.-R.31
Zhang, B.-C.32
Wang, J.-B.33
Wu, Y.34
Zhang, Q.-N.35
Qian, G.-S.36
Kuang, S.-Y.37
Fang, S.38
Li, Y.-F.39
Yu, L.-Y.40
Prochaska, H.J.41
Davidson, N.E.42
Gordon, G.B.43
Gorman, M.B.44
Zarba, A.45
Enger, C.46
Muñoz, A.47
Helzlsouer, K.J.48
Groopman, J.C.49
more..
-
62
-
-
0033577057
-
1 by oltipraz in residents of Qidong, People's Republic of China
-
(1999)
J. Natl. Cancer Inst.
, vol.91
, pp. 347-354
-
-
Wang, J.-S.1
Shen, X.2
He, X.3
Zhu, Y.-R.4
Zhang, B.-C.5
Wang, J.-B.6
Qian, G.-S.7
Kuang, S.-Y.8
Zarba, A.9
Egner, P.A.10
Jacobson, L.J.11
Muñoz, A.12
Helzlsouer, K.J.13
Groopman, J.D.14
Kensler, T.W.15
|